Good Grief for School Professionals
Good Grief for School Professionals trains school professionals to support grieving youth with confidence and compassion. This in-person workshop is designed for school professionals wanting to build their skills to effectively support students who are grieving. Through this training, school professionals will gain an understanding of children’s grief at different developmental stages, identify indicators of grief, and learn about current grief theory. This workshop will include interactive exercises and attendees will be provided with educational handouts, samples of grief-based activities, a...Read morend templates for creating student support plans.
Breakfast will be provided.
For questions, please contact Yesica Lemus at yesica@bosplace.org or 713-942-8339. Less...
Learning Objectives
- Describe several indicators of grief as a full-body experience.
- Distinguish children’s understanding of death at different developmental stages.
- Identify helpful ways to support grieving children and teens in the school setting.
Friday, September 11, 2026
10050 Buffalo Speedway, Houston, TX, 77054
09:00 AM CDT - 12:00 PM CDT
Click Here to Register
About the speakers
Agenda
9:00am-10:30am:
- Introduction to grief
- About Bo's Place
- Understanding children's grief
10:30am-12:00pm:
- Understanding children’s grief
- Supporting bereaved students
- School-wide situations
- Supporting you
CE Information - Earn 3 CE Credit Hours
CE Approvals
Joint Accreditation
American Psychological Association
New York Education Department's State Board for Social Work
New York Education Department Board of Creative Arts Therapy
New York State Education Department's State Board for Psychology
New York Education Department's State Board for Marriage and Family Therapy
Disclosure
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPSCE Learning Systems adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Medical Education. Any individuals in a position to control the content of a CE activity ― including faculty, planners, reviewers, or others ― are required to disclose all relevant financial relationships with ineligible entities (formerly known as commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
The following relevant financial relationships have been disclosed by this activity’s planners, faculty, and the reviewer:
PLANNERS AND REVIEWER
The planners of this activity have reported that they have no relevant financial relationships.
FACULTY
Dr. <
Consultant - AbbVie, ANeuroTech (division of Anima BV), Signant Health, Magstim, Inc., Intra-Cellular Therapies, Inc., EMA Wellness, Sage, Silo Pharma, Engrail Therapeutics, Pasithea Therapeutic Corp., GoodCap Pharmaceuticals, Inc., Senseye, Clexio, Ninnion Therapeutics, EmbarkNeuro, SynapseBio, BioXcel Therapeutics, Relmada Therapeutics
Ownership Interest - Seattle Genetics, Antares, Inc., Corcept Therapeutics Pharmaceuticals Company, EMA Wellness, Naki Health, Relmada Therapeutics
Advisor - ANeuroTech (division of Anima BV), Brain and Behavior Research Foundation (BBRF), Anxiety and Depression Association of America (ADAA), Skyland Trail, Signant Health, Laureate Institute for Brain Research (LIBR), Inc., Heading Health, Pasithea Therapeutic Corp., Sage
Executive Role - Gratitude America, ADAA, Lucy Scientific Discovery, Inc.
Royalty Or Patent Beneficiary - Method and devices for transdermal delivery of lithium (US 6,375,990B1) Method of assessing antidepressant drug therapy via transport inhibition of monoamine neurotransmitters by ex vivo assay (US 7,148,027B2)